Rate Versus Rhythm Control for Atrial Fibrillation.

Area of Science:

• Cardiology
• Electrophysiology
• Medical Therapy

Background:

• Symptomatic atrial fibrillation (AF) treatment with antiarrhythmic drugs generally improves symptoms and exercise tolerance.
• Large trials show no mortality benefit for rhythm-control versus rate-control strategies in AF.
• Catheter ablation alleviates symptoms and improves quality of life in patients refractory to medical therapy.

Purpose of the Study:

• To evaluate the efficacy of current treatments for symptomatic atrial fibrillation (AF).
• To highlight the limitations of existing therapies regarding mortality benefits and structural remodeling.
• To emphasize the importance of addressing modifiable risk factors for AF management.

Main Methods:

• Review of large randomized trials on AF rhythm-control versus rate-control strategies.
• Analysis of studies assessing catheter ablation outcomes in patients with AF.
• Consideration of the role of structural remodeling in AF pathophysiology.

Main Results:

• Antiarrhythmic drug therapy improves symptom scores and exercise tolerance in AF patients.
• No significant mortality benefit was demonstrated for rhythm-control compared to rate-control strategies.
• Catheter ablation effectively alleviates symptoms and enhances quality of life post-medical therapy failure.

Conclusions:

• While treatments improve AF symptoms, they do not confer a mortality advantage.
• Catheter ablation is effective for symptom management but does not reverse underlying structural changes.
• Patient education on modifiable factors is essential to prevent AF recurrence and structural remodeling.